PepGen

PEPGNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$160.336 M

$2.32 -5.51%

Close of 6 Nov 2026

As of 6 Nov 2026, PepGen (PEPG) has a market capitalization of $160.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$89.7M

Loss-making

Shares outstanding

69,259,517

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#258Zentalis PharmaceuticalsZNTL$162.8M
#259Oramed PharmaceuticalsORMP$162.6M
#260PepGenPEPG$160.3M
#261Canton StrategicCNTN$152.6M
#262Inovio PharmaceuticalsINO$150.4M

What if PepGen were worth as much as…

Open the what-if tool →

Gold $28.2T

$407,696.66

Per share 176,111× higher

Bitcoin $1.53T

$22,059.76

Per share 9,529× higher

Apple $5.02T

$72,420.12

Per share 31,283× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for PepGen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.